CVR: 45618706
Secondary names: Efflux Pharma ApS
Selskabets formål er at forske, udvikle, producere og sælge lægemidler og lægemiddelkandidater samt relaterede teknologier.
Nils Aage Brünner joined as ADM. DIR.
Kasper Pasternak Jørgensen left as ADM. DIR.
PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB appointed as auditor
Kasper Pasternak Jørgensen joined as ADM. DIR.
Resistance Oncology ApS registered with 100% ownership
was founded
Companies in the same industry and area
CVR 45506983
CVR 44695065
CVR 29418888
CVR 29769796
CVR 34892970
companydata.dk